ArticleInvestigational new drugs2016

A phase I study of the investigational NEDD8-activating enzyme inhibitor pevonedistat (TAK-924/MLN4924) in patients with metastatic melanoma.

Shailender Bhatia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.